Shinjuku, Japan

Yutaka Miyazaki

This inventor holds 2 USPTO granted patents. Top assignee: Mochida Pharmaceutical Co., Ltd.. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutaka Miyazaki. Retrieved from https://idiyas.com/inventor/yutaka-miyazaki-or8x2wwv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Shinjuku-ku, JP (2003)
  • Shinjuku, JP (2004)

Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yutaka Miyazaki: Innovator in Pharmaceutical Research

Introduction

Yutaka Miyazaki is a prominent inventor based in Shinjuku, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Miyazaki's latest patents include innovative compounds such as 4-hydroxypiperidine derivatives that exhibit antiarrhythmic activity. Additionally, he has developed agents specifically aimed at treating neuropathic pain. These advancements highlight his commitment to addressing critical health issues through innovative solutions.

Career Highlights

Yutaka Miyazaki is currently employed at Mochida Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work at this esteemed company has allowed him to collaborate with other talented researchers and contribute to the development of new therapeutic agents.

Collaborations

Miyazaki has worked alongside notable colleagues such as Ichiro Yamamoto and Manabu Itoh. Their collaborative efforts have further enhanced the research and development initiatives at Mochida Pharmaceutical Co., Ltd.

Conclusion

Yutaka Miyazaki's contributions to pharmaceutical research and his innovative patents underscore his role as a key figure in the industry. His dedication to developing effective treatments continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…